So let me see if I have this right. AXP tells the market about a study that compares saline vs aeroform. The results are totally consistent with the information already in the marketplace, albeit somewhat quantified. This relates to infection, ease of use, timeframes, success rates etc.
So you delve into the text to find something and you find radiology! really? Even whatisname (Franks predecessor) told us about this in 2017.
Looks to me like you lost money on this and want to blame somebody else.
Ann: AirXpanders announces results of breast reconstruction study, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $2.276K | 2.275M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 36646903 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 82664099 | 41 |
View Market Depth
| Last trade - 11.04am 25/07/2025 (20 minute delay) ? |
| AXP (ASX) Chart |